DOP077 Low-dose budesonide maintains clinical remission and quality of life in collagenous colitis over a one year period: Results from the randomised, placebo-controlled BUC-63/COC trial | Zendy

AI Assistant Blog Pricing

DOP077 Low-dose budesonide maintains clinical remission and quality of life in collagenous colitis over a one year period: Results from the randomised, placebo-controlled BUC-63/COC trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.